MCCORMICK FRANK 4
4 · BridgeBio Pharma, Inc. · Filed Jun 26, 2025
Insider Transaction Report
Form 4
MCCORMICK FRANK
Director
Transactions
- Sale
Common Stock
2025-06-24$44.23/sh−100,000$4,422,800→ 879,979 total(indirect: By Trust)
Holdings
- 83,275
Common Stock
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on August 28, 2024.
- [F2]Represents the weighted average sale price of the shares sold from $44.00 to $44.69 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.